ERBB2 and breast carcinoma: We confirmed affinity of the three anti-HER2 rat IgE antibodies to human FcεRI and hHER2 (Supplementary Fig. 5) and binding to rHER2-expressing MTLn3 breast cancer cells (Fig. 4B).